CN Patent

CN105601614A — 一种色瑞替尼晶型及其制备方法

Assigned to SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co Ltd · Expires 2016-05-25 · 10y expired

What this patent protects

本发明公开了一种色瑞替尼晶型C、无定形物及其制备方法和用途。具体地，本发明提供了色瑞替尼无定形物和晶型C以及其分别的制备方法。本发明所提供的制备方法制得的色瑞替尼无定形物具有良好的溶解性；所制得的色瑞替尼晶型C具有良好的热稳定性等优点。

USPTO Abstract

本发明公开了一种色瑞替尼晶型C、无定形物及其制备方法和用途。具体地，本发明提供了色瑞替尼无定形物和晶型C以及其分别的制备方法。本发明所提供的制备方法制得的色瑞替尼无定形物具有良好的溶解性；所制得的色瑞替尼晶型C具有良好的热稳定性等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN105601614A
Jurisdiction
CN
Classification
—
Expires
2016-05-25
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.